Literature DB >> 26018683

Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.

Aurore Goineau1, Mathilde Colombié, Caroline Rousseau, Sophie Sadot-Lebouvier, Stéphane Supiot.   

Abstract

Combined PET/CT scanning with (18)F-FDG is in current use in Hodgkin lymphoma. New tracers have been developed, such as (18)F-choline in prostate cancer. Its use is under investigation in other solid tumors (eg, brain, liver, lung). We report a case of Hodgkin lymphoma incidentally detected on (18)F-choline PET/CT in a prostate cancer patient and show a comparison with (18)F-FDG PET/CT. (18)F-choline PET/CT detected more lymph node lesions than the (18)F-FDG PET/CT for this patient. Comparative studies of the 2 tracers might help fine-tune treatments and, in particular, delineate target zones in radiation therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26018683     DOI: 10.1097/RLU.0000000000000817

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.

Authors:  Loic Ah-Thiane; Ludovic Ferrer; Bruno Maucherat; Vincent Fleury; Maelle Le Thiec; Daniela Rusu; Caroline Rousseau
Journal:  Clin Nucl Med       Date:  2022-04-27       Impact factor: 10.782

Review 2.  [Hemato-oncological imaging : Importance of hybrid procedures].

Authors:  M E Mayerhoefer; A Haug
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

3.  Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.

Authors:  Martina Sollini; Francesco Pasqualetti; Marzio Perri; Gabriele Coraggio; Paolo Castellucci; Massimo Roncali; Roberto Boni; Elena Lazzeri; Maria Galeandro; Fabiola Paiar; Annibale Versari; Paola Anna Erba
Journal:  Cancer Imaging       Date:  2016-08-31       Impact factor: 3.909

Review 4.  ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies.

Authors:  Samantha Gokhale; Ping Xie
Journal:  Pharmaceutics       Date:  2021-06-20       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.